Yahoo Web Search

Search results

    • Q1 2024 Ocugen Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 hours ago

      Now there is real hope for all RP patients who haven't had a treatment option. Our completion of enrolment and dosing in Phase 1/2 trial demonstrated promising safety and efficacy across various ...

    • A Brain Breakthrough 25 Years in the Making

      A Brain Breakthrough 25 Years in the Making

      The Scientist· 1 day ago

      The patient had spinocerebellar ataxia type 4 (SCA4), a progressive neurodegenerative disease that causes muscle weakness, movement difficulty, and loss...